Keurig Dr Pepper Inc. (NasdaqGS:KDP) entered into a definitive agreement to acquire Global Rights of Atypique from Station Agro-Biotech on June 23, 2022. The agreement includes a multi-year collaboration between the two companies to fuel accelerated growth for Atypique, leveraging Station Agro-Biotech's R&D expertise in the category and KDP's robust sales and distribution network. The deal is expected to close in early Q4.

Keurig Dr Pepper Inc. (NasdaqGS:KDP) completed the acquisition of Global Rights of Atypique from Station Agro-Biotech for CAD 30 million on September 1, 2022.